A case-control study by Mao Y et al. [49] demonstrated that serum GP73 in patients with HCC was significantly elevated than compared to those in healthy adults and hepatitis B virus (HBV) carriers without hepatic disease. This evidence concerns the gene GOLM1 and hepatocellular carcinoma.